Survival Time is Problematic as an Indicator of an anti- AML Drug ’s Effectiveness

“Complete response” (CR) in AML was originally recognized as a distinct response when because people who met the criteria for CR (ANC> 1,000, platelet count> 100,000, marrow with

Source: Clinical Lymphoma, Myeloma and Leukemia - September 1, 2017 Category: Hematology Authors: Carole Shaw, Shelly Hager, Mary-Elizabeth Percival, Roland Walter, Pamela Becker, Kathleen Shannon-Dorcy, Elihu Estey, Kelda Gardner Source Type: research